Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

SmithKline Beecham and Leo will collaborate on dermatological R&D

May 21, 1998

IL-8 receptor antagonists described by SKB

May 19, 1998

FDA grants approval for pivotal clinical trial of Repel

May 12, 1998

Compounds for IL-8-mediated diseases in development at SmithKline Beecham

May 11, 1998

Ortec's CCS granted humanitarian use device designation

May 11, 1998

Favorable results obtained in SomatoKine burn study

May 7, 1998

Solarase receives additional European approvals

May 5, 1998

Topical BCX-34 not effective in phase II

May 4, 1998

hu1124 shows clinical activity in phase I for psoriasis

April 30, 1998

Milkhaus granted patent for scar treatment agent

April 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...